Rapport Therapeutics, Inc. RAPP Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapport Therapeutics, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapport Therapeutics, Inc.'s operating lease ROU assets?
- Rapport Therapeutics, Inc. (RAPP) reported operating lease ROU assets of $9.33M in Q1 2026.
- How has Rapport Therapeutics, Inc.'s operating lease ROU assets changed year-over-year?
- Rapport Therapeutics, Inc.'s operating lease ROU assets increased by 24.9% year-over-year, from $7.47M to $9.33M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s operating lease ROU assets?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s operating lease ROU assets has grown at a 118.1% compound annual growth rate (CAGR), from $2.08M to $9.91M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.